Literature DB >> 18273479

Very late thrombosis in a bare metal stent: an under-recognized problem.

Massimo Fineschi1, Tommaso Gori.   

Abstract

Recent publications have emphasized the concept that restenosis of a bare metal stent is not as clinically benign as previously believed. A case of very late (seven years) thrombosis after implantation of a bare metal stent is described. While doubts on the long-term safety of drug-eluting stents are debated, registry data and clinical reports suggest that the long-term safety of coronary bare metal stent implantation should also be reconsidered.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18273479      PMCID: PMC2645291          DOI: 10.1016/s0828-282x(08)70575-0

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  7 in total

1.  Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET).

Authors:  Christoph Kaiser; Hans Peter Brunner-La Rocca; Peter T Buser; Piero O Bonetti; Stefan Osswald; André Linka; Alain Bernheim; Andreas Zutter; Michael Zellweger; Leticia Grize; Matthias E Pfisterer
Journal:  Lancet       Date:  2005 Sep 10-16       Impact factor: 79.321

2.  Recurrent very late stent thrombosis after bare-metal stent implantation.

Authors:  T Saito; H Asajima
Journal:  Catheter Cardiovasc Interv       Date:  2007-07-01       Impact factor: 2.692

3.  Late or very late stent thrombosis can also occur with bare metal stents.

Authors:  Andres Rosas Ramos; Marie-claude Morice; Thierry Lefèvre
Journal:  Catheter Cardiovasc Interv       Date:  2007-08-01       Impact factor: 2.692

4.  Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.

Authors:  Matthias Pfisterer; Hans Peter Brunner-La Rocca; Peter T Buser; Peter Rickenbacher; Patrick Hunziker; Christian Mueller; Raban Jeger; Franziska Bader; Stefan Osswald; Christoph Kaiser
Journal:  J Am Coll Cardiol       Date:  2006-11-02       Impact factor: 24.094

5.  Bare metal stent restenosis is not a benign clinical entity.

Authors:  Michael S Chen; Jim M John; Derek P Chew; David S Lee; Stephen G Ellis; Deepak L Bhatt
Journal:  Am Heart J       Date:  2006-06       Impact factor: 4.749

6.  Histopathological findings of new in-stent lesions developed beyond five years.

Authors:  Katsuyuki Hasegawa; Hideo Tamai; Eisho Kyo; Kunihiko Kosuga; Shigeru Ikeguchi; Tatsuhiko Hata; Masaharu Okada; Shinya Fujita; Takafumi Tsuji; Shinsaku Takeda; Rei Fukuhara; Yuetsu Kikuta; Seiichiro Motohara; Kazuo Ono; Eiji Takeuchi
Journal:  Catheter Cardiovasc Interv       Date:  2006-10       Impact factor: 2.692

7.  Effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis: the TRUE (Tuscany Registry of Sirolimus for Unselected In-Stent Restenosis) Registry.

Authors:  Francesco Liistro; Massimo Fineschi; Paolo Angioli; Giuseppe Sinicropi; Giovanni Falsini; Tommaso Gori; Kenneth Ducci; Achille Bravi; Leonardo Bolognese
Journal:  J Am Coll Cardiol       Date:  2006-06-23       Impact factor: 24.094

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.